Successful use of idarucizumab as a reversal agent for dabigatran in a patient with acute dissected aortic aneurysm.
Anna
A
Tomaszuk-Kazberuk
Paulina
P
Łopatowska
Elżbieta
E
Młodawska
Joanne
J
van Ryn
Paul A
PA
Reilly
Charles V
CV
Pollack
D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D000991:Antithrombins / Q000627:therapeutic use; D001014:Aortic Aneurysm / Q000000981:diagnostic imaging* / Q000601:surgery; D001777:Blood Coagulation / Q000187:drug effects*; D000069604:Dabigatran / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D014656:Vascular Surgical Procedures
D061067:Antibodies, Monoclonal, Humanized; D000991:Antithrombins; C000594745:idarucizumab; D000069604:Dabigatran